SS

Seema Srivastava

Active Director Director DIN 11156054
DIN 11156054 First appointment Jun 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Seema Srivastava

Data last updated:

Seema Srivastava is a Director at Kbs Health Care Private Limited (since 2025).

DIN 11156054
Primary Designation Director
First Appointment 16 Jun 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kbs Health Care Private Limited U86100UP2025PTC226156
Director16 Jun 20252025Active

Board colleagues of Seema Srivastava

Directorship timeline

Open interactive timeline →
Kbs Health Care Private Limited
Premium access

Shareholding and investment profile for Seema Srivastava

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Seema Srivastava

Seema Srivastava currently holds 1 directorship: Kbs Health Care Private Limited (Director, since 16 Jun 2025).

Seema Srivastava was first appointed on 16 Jun 2025 as Director at Kbs Health Care Private Limited.

The current boards of Seema Srivastava's companies include Paarth Srivastav (Kbs Health Care Private Limited), Sashwat Srivastava (Kbs Health Care Private Limited), Vipin Srivastava (Kbs Health Care Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available